Jörn M Schattenberg: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial

Traussnigg, Stefan, Schattenberg, Jörn M, Demir, Münevver, Wiegand, Johannes, Geier, Andreas, Teuber, Gerlinde, Hofmann, Wolf Peter, Kremer, Andreas E, Spreda, Frank, Kluwe, Johannes, Petersen, Jörg,

Journal:

The Lancet Gastroenterology & Hepatology

Year:

2019

Language:

english

File:

PDF, 825 KB

english, 2019

2

Welches (ist das richtige) Target bei nichtalkoholischer Fettleber (NAFLD)

Huber, Yvonne, Galle, Peter R., Schattenberg, Jörn M.

Journal:

Zeitschrift für Gastroenterologie

Year:

2020

File:

PDF, 180 KB

2020

3

Health-related quality of life in patients with compensated and decompensated liver cirrhosis

Labenz, Christian, Toenges, Gerrit, Schattenberg, Jörn M., Nagel, Michael, Huber, Yvonne, Marquardt, Jens U., Galle, Peter R., Wörns, Marcus-Alexander

Journal:

European Journal of Internal Medicine

Year:

2019

Language:

english

File:

PDF, 640 KB

english, 2019

4

Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation

Gehrke, Nadine, Hövelmeyer, Nadine, Waisman, Ari, Straub, Beate K., Weinmann-Menke, Julia, Wörns, Marcus A., Galle, Peter R., Schattenberg, Jörn M.

Journal:

Journal of Hepatology

Year:

2018

Language:

english

File:

PDF, 1.15 MB

english, 2018

5

Animal-Naming-Test – Tiere als diagnostischer Ausweg?

Labenz, Christian, Schattenberg, Jörn

Journal:

Zeitschrift für Gastroenterologie

Year:

2018

Language:

german

File:

PDF, 70 KB

german, 2018

6

Effectiveness of lifestyle interventions in NALFD (non-alcoholic fatty liver disease) – how are clinical trials affected?

Michel, Maurice, Schattenberg, Jörn M.

Journal:

Expert Opinion on Investigational Drugs

Year:

2020

Language:

english

File:

PDF, 898 KB

english, 2020

7

The potential of silymarin for the treatment of hepatic disorders

Hellerbrand, Claus, Schattenberg, Jörn M., Peterburs, Philipp, Lechner, Anja, Brignoli, Reto

Journal:

Clinical Phytoscience

Year:

2017

Language:

english

File:

PDF, 866 KB

english, 2017

8

Mouse models of nonalcoholic steatohepatitis Towards optimization of their relevance to human NASH

Farrell, Geoff, Schattenberg, Jörn M., Leclercq, Isabelle, Yeh, Matthew M., Goldin, Robert, Teoh, Narci, Schuppan, Detlef

Journal:

Year:

2018

Language:

english

File:

PDF, 2.10 MB

english, 2018

9

Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centers

Krawczyk, Marcin, Bantel, Heike, Rau, Monika, Schattenberg, Jörn M., Grünhage, Frank, Pathil, Anita, Demir, Münevver, Kluwe, Johannes, Boettler, Tobias, Weber, Susanne N., Geier, Andreas, Lammert, Fra

Journal:

Journal of Human Genetics

Year:

2018

Language:

english

File:

PDF, 490 KB

english, 2018

10

SAT-069-Interleukin 6: A marker for hepatic encephalopathy

Labenz, Christian, Huber, Yvonne, Michael, Nagel, Marquardt, Jens, Galle, Peter, Jörn, PD Dr. Schattenberg, Wörns, Marcus-Alexander

Journal:

Journal of Hepatology

Year:

2019

Language:

english

File:

PDF, 57 KB

english, 2019

11

Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B

Jens M. Kittner, Martin F. Sprinzl, Annette Grambihler, Arndt Weinmann, Jörn M. Schattenberg, Peter R. Galle, Marcus Schuchmann

Journal:

Journal of Clinical Virology

Year:

2012

Language:

english

File:

PDF, 291 KB

english, 2012

12

76 Hepatic insulin signaling is inhibited by CYP2E1-overexpression

Jörn M. Schattenberg, Yongjun Wang, Raina M. Rigoli, Mark J. Czaja

Journal:

Year:

2003

Language:

english

File:

PDF, 149 KB

english, 2003

13

Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis

Labenz, Christian, Toenges, Gerrit, Huber, Yvonne, Nagel, Michael, Marquardt, Jens U., Schattenberg, Jörn M., Galle, Peter R., Labenz, Joachim, Wörns, Marcus-Alexander

Journal:

American Journal of Gastroenterology

Year:

2019

File:

PDF, 292 KB

2019

14

Reading the stars for hepatic fibrosis or how to predict the severity of liver disease in patients with NASH

Schattenberg, Jörn M.

Journal:

Liver International

Year:

2019

Language:

english

File:

PDF, 293 KB

english, 2019

15

Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy

Labenz, Christian, Toenges, Gerrit, Huber, Yvonne, Nagel, Michael, Marquardt, Jens U., Schattenberg, Jörn M., Galle, Peter R., Labenz, Joachim, Wörns, Marcus-Alexander

Journal:

Alimentary Pharmacology & Therapeutics

Year:

2019

Language:

english

File:

PDF, 623 KB

english, 2019

16

Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways

Jorn Markus Schattenberg, Marcus Schuchmann, Peter Robert Galle

Journal:

Journal of Gastroenterology and Hepatology

Year:

2011

Language:

english

File:

PDF, 244 KB

english, 2011

17

Show me your signaling– and I’ll tell you who you are

Jörn M. Schattenberg, Peter R. Galle

Journal:

Journal of Hepatology

Year:

2009

Language:

english

File:

PDF, 80 KB

english, 2009

18

Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling

Schattenberg, Jörn M., Czaja, Mark J.

Journal:

Year:

2014

Language:

english

File:

PDF, 769 KB

english, 2014

19

NASH – Ist die Zeit für eine medikamentöse Therapie gekommen?

Labenz, Christian, Schattenberg, Jörn

Journal:

Zeitschrift für Gastroenterologie

Year:

2016

Language:

german

File:

PDF, 98 KB

german, 2016

20

Refining non-invasive diagnostics in NAFLD - closing the gap to detect advanced fibrosis

Schattenberg, Jörn M., Loomba, und Rohit

Journal:

Year:

2018

Language:

english

File:

PDF, 97 KB

english, 2018

21

Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC)

Kaps, Leonard, Grambihler, Annette, Yemane, Bethlehem, Nagel, Michael, Labenz, Christian, Ploch, Pascal, Michel, Maurice, Galle, Peter R., Wörns, Marcus-Alexander, Schattenberg, Jörn M.

Journal:

Digestive Diseases and Sciences

Year:

2019

File:

PDF, 711 KB

2019

22

Nonalcoholic steatohepatitis

Schattenberg, Jörn M., Schuppan, Detlef

Journal:

Current Opinion in Lipidology

Year:

2011

Language:

english

File:

PDF, 332 KB

english, 2011

23

Leberzirrhose und hepatorenales Syndrom: Das Ansprechen auf Terlipressin und Albumin ist mit besserem Überleben assoziiert

Nguyen-Tat, Marc, Götz, Esther, Scholz-Kreisel, Peter, Ahrens, Juliane, Sivanathan, Visvakanth, Schattenberg, Jörn, Rey, Johannes, Wörns, Marcus-Alexander, Galle, Peter, Marquardt, Jens

Journal:

DMW - Deutsche Medizinische Wochenschrift

Year:

2015

Language:

german

File:

PDF, 295 KB

german, 2015

24

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

Taylor, Rod S., Taylor, Rebecca J., Bayliss, Sue, Hagstrom, Hanes, Nasr, Patrik, Schattenberg, Jorn M., Ishigami, Masatoshi, Toyoda, Hidenori, Wai-Sun Wong, Vincent, Peleg, Noam, Shlomai, Amir, Sebast

Journal:

Gastroenterology

Year:

2020

File:

PDF, 835 KB

2020

25

PS-179-Analysis of long-term persistence of HCV resistance-associated substitutions within NS, NS5A and NS5B in genotype 1 and 3 after DAA treatment failure

Dietz, Julia, Vermehren, Johannes, Welzel, Tania, Müllhaupt, Beat, Buggisch, Peter, Kathrin, Matschenz, Jörn, PD Dr. Schattenberg, Antoni, Christoph, Mauss, Stefan, Durmashkina, Elena, Niederau, Claus

Journal:

Journal of Hepatology

Year:

2019

Language:

english

File:

PDF, 54 KB

english, 2019

26

SAT-067-Prospective assessment of sarcopenia as a prognostic factor for survival in patients with liver cirrhosis

Kremer, Wolfgang Maximilian, Koch, Sandra, Lochner, Dorothea, Koch, Anna Christina, Hahn, Felix, Grambihler, Annette, Labenz, Christian, Jorn, PD Dr. Schattenberg, Duber, Christoph, Galle, Peter Rober

Journal:

Journal of Hepatology

Year:

2019

Language:

english

File:

PDF, 70 KB

english, 2019

27

A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma

Michel, Maurice, Kalliga, Eva, Labenz, Christian, Straub, Beate K., Wörns, Marcus-Alexander, Galle, Peter R., Schattenberg, Jörn M.

Journal:

Zeitschrift für Gastroenterologie

Year:

2020

File:

PDF, 393 KB

2020

28

Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir

Bernuth, Sebastian, Yagmur, Eray, Schuppan, Detlef, Sprinzl, Martin F., Zimmermann, Anca, Schad, Arno, Kittner, Jens M., Weyer, Veronika, Knapstein, Johanna, Schattenberg, Jörn M., Wörns, Marcus A., G

Journal:

Digestive and Liver Disease

Year:

2015

Language:

english

File:

PDF, 855 KB

english, 2015

29

SAT-349-Improvement of hepatic inflammation and fibrosis independently of weight loss from a short, individualized, web-based exercise program in patients with NAFLD

Huber, Yvonne, Pfirrmann, Daniel, Labenz, Christian, Kalliga, Eva, Gehrke, Nadine, Straub, Beate, Leeming, Diana, Bantel, Heike, Galle, Peter, Simon, Perikles, Jörn, PD Dr. Schattenberg

Journal:

Journal of Hepatology

Year:

2019

Language:

english

File:

PDF, 226 KB

english, 2019

30

LBO-02-Elafibranor, a peroxisome proliferator-activted receptor alpha and delta agonist demonstrates favourable efficacy and safety in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid treatment

Jörn, PD Dr. Schattenberg, Parés, Albert, Kowdley, Kris V., Heneghan, Michael, Caldwell, Stephen, Pratt, Daniel, Bonder, Alan, Hirschfield, Prof. Gideon M., Bchir, MB, LEVY, Cynthia, Vierling, John, J

Journal:

Journal of Hepatology

Year:

2019

Language:

english

File:

PDF, 50 KB

english, 2019

31

CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling

Jörn M. Schattenberg, Yongjun Wang, Raina M. Rigoli, Dennis R. Koop, Mark J. Czaja

Journal:

Year:

2004

Language:

english

File:

PDF, 419 KB

english, 2004

32

Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat

Daniel Benten, Vinay Kumaran, Brigid Joseph, Jörn Schattenberg, Yury Popov, Detlef Schuppan, Sanjeev Gupta

Journal:

Year:

2005

Language:

english

File:

PDF, 820 KB

english, 2005

33

Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)

Tim Zimmermann, Maria Hoppe-Lotichius, Vuk Tripkovic, Ana P. Barreiros, Thomas C. Wehler, Anca Zimmermann, Jörn M. Schattenberg, Michael Heise, Stefan Biesterfeld, Peter R. Galle, Gerd Otto, Marcus Sc

Journal:

European Journal of Internal Medicine

Year:

2010

Language:

english

File:

PDF, 208 KB

english, 2010

34

Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo

Jörn M. Schattenberg, Tim Zimmermann, Marcus Wörns, Martin F. Sprinzl, Andreas Kreft, Tobias Kohl, Michael Nagel, Jürgen Siebler, Henning Schulze Bergkamen, You-Wen He, Peter R. Galle, Marcus Schuchma

Journal:

Journal of Hepatology

Year:

2011

Language:

english

File:

PDF, 1.44 MB

english, 2011

35

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection

Bourgeois, Stefan, Van Vlierberghe, Hans, Moreno, Christophe, Orlent, Hans, Nevens, Frederik, Arastéh, Keikawus, Horsmans, Yves, Schattenberg, Jörn M., Buggisch, Peter, Francque, Sven, Vijgen, Leen, K

Journal:

BMC Gastroenterology

Year:

2017

Language:

english

File:

PDF, 614 KB

english, 2017

36

Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors’ reply

Labenz, Christian, Schattenberg, Jörn M.

Journal:

Alimentary Pharmacology & Therapeutics

Year:

2018

Language:

english

File:

PDF, 230 KB

english, 2018

37

Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy

Labenz, Christian, Toenges, Gerrit, Huber, Yvonne, Nagel, Michael, Marquardt, Jens U., Schattenberg, Jörn M., Galle, Peter R., Labenz, Joachim, Wörns, Marcus-Alexander

Journal:

Alimentary Pharmacology & Therapeutics

Year:

2019

File:

PDF, 623 KB

2019

38

Shortcut to death

Jörn M. Schattenberg, Marcus Schuchmann

Journal:

Year:

2009

Language:

english

File:

PDF, 396 KB

english, 2009

39

CYP2E1 expression sensitizes hepatocytes to death from polyunsaturated fatty acids through ERK signaling

Schattenberg, Jorn M., Wang, Yongjun, Rigoli, Raina M., Czaja, Mark J.

Journal:

Gastroenterology

Year:

2003

Language:

english

File:

PDF, 497 KB

english, 2003

40

SAT-348-Low frequencies of lifestyle interventions and liver-specific medications in a multicentric prospective real world NAFLD cohort: The fatty liver assessment in Germany (FLAG) study

Hofmann, Wolf Peter, Jörn, PD Dr. Schattenberg, Dikopoulos, Nektarios, Lammert, Frank, Heyne, Renate, Schwenzer, Jeannette, Manns, Michael P., Muche, Marion, Schubert, Lisa, Ingiliz, Patrick, Schmidt,

Journal:

Journal of Hepatology

Year:

2019

Language:

english

File:

PDF, 58 KB

english, 2019

41

Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis

Labenz, Christian, Toenges, Gerrit, Huber, Yvonne, Nagel, Michael, Marquardt, Jens U., Schattenberg, Jörn M., Galle, Peter R., Labenz, Joachim, Wörns, Marcus-Alexander

Journal:

American Journal of Gastroenterology

Year:

2019

Language:

english

File:

PDF, 292 KB

english, 2019

42

Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany

Labenz, Christian, Huber, Yvonne, Michel, Maurice, Nagel, Michael, Galle, Peter R., Kostev, Karel, Schattenberg, Jörn M.

Journal:

Digestive Diseases and Sciences

Year:

2019

File:

PDF, 1.21 MB

2019

43

Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

Labenz, Christian, Prenosil, Vera, Koch, Sandra, Huber, Yvonne, Marquardt, Jens U., Schattenberg, Jörn M., Galle, Peter R., Weinmann, Arndt, Wörns, Marcus-Alexander

Journal:

Digestive Diseases

Year:

2017

Language:

english

File:

PDF, 126 KB

english, 2017

44

Intravenöses L-Ornithin L-Aspartat — mehr als nur Aminosäuren?

Labenz, Christian, Schattenberg, Jörn M.

Journal:

Year:

2018

File:

PDF, 146 KB

2018

45

163 Hepatocyte resistance to oxidative stress is dependent on PKC-mediated down-regulation of JNK/AP-1

Yongjun Wang, Jörn M. Schattenberg, Raina M. Rigoli, Mark J. Czaja

Journal:

Year:

2003

Language:

english

File:

PDF, 152 KB

english, 2003

46

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma

Weinmann, Arndt, Alt, Yvonne, Koch, Sandra, Nelles, Carina, Düber, Christoph, Lang, Hauke, Otto, Gerd, Zimmermann, Tim, Marquardt, Jens U, Galle, Peter R, Wörns, Marcus A, Schattenberg, Jörn M

Journal:

Year:

2015

Language:

english

File:

PDF, 641 KB

english, 2015

47

Diabetes and apoptosis: liver

Jörn M. Schattenberg, Marcus Schuchmann

Journal:

Year:

2009

Language:

english

File:

PDF, 357 KB

english, 2009

48

Apoptosis in liver disease

Jörn M. Schattenberg, Peter R. Galle, Marcus Schuchmann

Journal:

Liver International

Year:

2006

Language:

english

File:

PDF, 288 KB

english, 2006

49

Extracellular Vesicles as Messengers between Hepatocytes and Macrophages in Nonalcoholic Steatohepatitis

Schattenberg, Jörn M., Lee, Myung-Shik

Journal:

Gastroenterology

Year:

2016

Language:

english

File:

PDF, 718 KB

english, 2016

50

The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs

Cook, Nigel, Geier, Andreas, Schmid, Andreas, Hirschfield, Gideon, Kautz, Achim, Schattenberg, Jörn M., Balp, Maria-Magdalena

Journal:

Frontiers in Medicine

Year:

2019

Language:

english

File:

PDF, 2.74 MB

english, 2019

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски